Find a Tender · Contract
NP47825 Multiple Sclerosis Medicines
A public procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.
- —
- Award value
- £51.5m
- Tender value
- 8
- Suppliers
- 9
- Awards
- 3
- Notices
- Contract
- Stage
Overview
Supply of multiple sclerosis medicines to NHS Scotland.
Key details
- Source
- Find a Tender
- Lifecycle stage
- Contract
- Status
- —
- CPV classification
- 33600000 — Pharmaceutical products
- Currency
- GBP
- Total award value
- —
- Tender value
- £51,517,832
- First published
- 7 Jan 2025
- Last updated
- 2 May 2025
Awards
9 awards recorded on this procurement.
| Supplier | Companies House | Awarded | Status | Value |
|---|---|---|---|---|
| Sandoz Ltd | 01547204 | — | active | — |
| Merck Serono Limited | 00990823 | — | active | — |
| Orifarm UK | 10015046 | — | active | — |
| Viatris UK Healthcare Ltd | 09189103 | — | active | — |
| Biogen Idec Ltd | 01497267 | — | active | — |
| Teva UK Ltd | 00302461 | — | active | — |
| STADA UK - Thornton & Ross | — | — | active | — |
| Ranbaxy (UK) Ltd | — | — | active | — |
| Teva UK Ltd | 00302461 | — | active | — |
Notice timeline
Every published notice in this procurement's lifecycle.
All suppliers
Frameworks & programmes
More from The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)
FAQs about this procurement
Who is the buyer for "NP47825 Multiple Sclerosis Medicines"?
NP47825 Multiple Sclerosis Medicines is a UK public-sector procurement published by The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) via Find a Tender.
Has "NP47825 Multiple Sclerosis Medicines" been awarded?
Yes — 9 awards are recorded, with a reported total value of £51,517,832. The current lifecycle stage is "Contract".
Which suppliers are involved in "NP47825 Multiple Sclerosis Medicines"?
8 suppliers are linked: Sandoz Ltd, Merck Serono Limited, Orifarm UK, Viatris UK Healthcare Ltd, Biogen Idec Ltd, Teva UK Ltd, STADA UK - Thornton & Ross, Ranbaxy (UK) Ltd.
What is "NP47825 Multiple Sclerosis Medicines" worth?
The reported tender value is £51,517,832.
When was "NP47825 Multiple Sclerosis Medicines" published?
It was first published on 7 Jan 2025 and last updated on 2 May 2025, across 3 notices.
Track procurements like this one
Enable monitors the entire UK public-contract pipeline — get alerts on buyers, suppliers and frameworks that matter to you.
Get in touch with Enable